The Effect of Age in Patients with Triple Vessel CAD Undergoing PCI vs. Surgery

Original Title: Effects of Age and Sex on Clinical Outcomes after Percutaneous Coronary Intervention Relative to Coronary Artery Bypass Grafting in Patients with Triple Vessel Coronary Artery Disease. Reference: KyoheiYamaji et al. Circulation. 2016 Mar 23. [Epub ahead of print].

 

Sex and age are factors that are often considered in the daily practice to decide between PCI or surgery.

The multicenter CREDO-Kyoto trial included 25816 patients; 5651 (men n=3998 and women n=1653) had triple vessel CAD and were considered good candidates for revascularization both with PCI and CABG (PCI n=3,165 and CABG n=2,486).

Patients were divided in three groups according to age tertile: ≤65 years (n=1,972), 66-73 years (n=1,820), and ≥74 years (n=1,859).

There was an excess mortality risk in ≥74 year old patients undergoing PCI compared to those undergoing CABG (HR 1.40, CI 95% 1.10 to 1.79; p=0.006), whereas this risk was neutral for ≤65 year old patients (HR 1.05, CI 95% 0.73 to 1.53; p=0.78) and also neutral for the group between 66 and 73 years of age (HR 1.03, CI 95% 0.78 to 1.36; p=0.85).

The excess mortality risk in the PCI group was significant in men (HR 1.24, CI 95% 1.03 to 1.50; p=0.02) and tended to be significant in women (HR 1.34 IC 95% 0.98 a 1.84; p=0.07).

Conclusion
There was a significant association between age and mortality risk in ≥74 year old patients with triple vessel CAD undergoing PCI compared to those undergoing CABG. The risk was neutral in younger patients.

More articles by this author

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Left Main Coronary Artery Disease: Intravascular Imaging-Guided PCI vs. Coronary Artery Bypass Grafting

Multiple randomized clinical trials have demonstrated superior outcomes with coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in patients with left main...

AHA 2025 | OCEAN Study: Anticoagulation vs. Antiplatelet Therapy After Successful Atrial Fibrillation Ablation

After a successful atrial fibrillation (AF) ablation, the need to maintain long-term anticoagulation (AC) remains uncertain, especially considering the very low residual embolic risk...

AHA 2025 | VESALIUS-CV: Evolocumab in High-Cardiovascular-Risk Patients Without Prior MI or Stroke

LDL cholesterol is a well-established factor for cardiovascular disease. Therapy with PCSK9 inhibitors, including evolocumab, has been shown to reduce the risk of cardiovascular...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....